CIN : U24233KL2007SGC021616
Visitors : 1593426
0471-2945600/46




Notices

Essential Drugs Division

E-tender for the Procurement of ALGLUCOSIDASE ALFA FOR INTRAVENOUS INFUSION 50mg vial for SATH under NPRD for the year 2025-26 – Technical Bid Evaluation –Status– Published

Essential Drugs Division

Re-tender for the Procurement of Drugs/Supplies for the year 2025-26- Corrigendum- Published – r

Essential Drugs Division

Re-tender for the Procurement of Drugs/Supplies for the year 2025-26 -Time Extension Notice - Published

Essential Drugs Division

KMSCL –Re-tender for the Procurement of Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published – reg.

Essential Drugs Division

–Re-tender for the Procurement of Specialty Drugs for the year 2025-26- – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

KMSCL-Re-tender for the Procurement of Drugs/Supplies pre-bid meeting for the year 2025-26 - MEETING LINK

Essential Drugs Division

KMSCL - Re-tender for the Procurement of Drugs/Supplies for the year 2025-26- Amendment - Published

Essential Drugs Division

e-tender for the Procurement of Anticancer Drugs (Category ACD) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

e-tender for the Procurement of SPECIALTY Drugs (Category SPL) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

e-tender for the Procurement of Drugs (Category III - VIII) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

e-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

e-tender for the Procurement of Drugs (Category III - VIII) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

e-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

Re-tender for the Procurement of Anti cancer Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/ACD/RT/2025/021 dated 16.07.2025

Essential Drugs Division

Re-tender for the Procurement of Specialty Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/SPL/RT/2025/020 dated 16.07.2025

Essential Drugs Division

Re-tender for the Procurement of Drugs/supplies for the year 2025-26 vide Re-tender No. KMSCL/ED/III to VIII/RT/2025/019 dated 16.07.2025

Essential Drugs Division

Re-tender for the Procurement of Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/I & II/RT/2025/018 dated 16.07.2025

Essential Drugs Division

Re-tender for the Procurement of Drugs for the year 2025-26 –Technical Bid Evaluation -List of selected/rejected bidders/products for price bid evaluation– Published

Essential Drugs Division

Re-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation –List of selected/rejected bidders/products for price bid evaluation– Published

Essential Drugs Division

KMSCL- e-tender for the procurement of Drugs for Rare Disease for the year 2025-26

Essential Drugs Division

KMSCL- E-tender for the Procurement of Drugs/ Supplies ( category III- VIII) for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg

Essential Drugs Division

KMSCL- E-tender for the Procurement of Anti- Cancer Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg

Essential Drugs Division

Technical Bid Evaluation of Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025-26

Essential Drugs Division

KMSCL- Re-tender for the procurement of Anti- Cancer Drugs for the year 2025-26

Essential Drugs Division

KMSCL- Re-tender for the procurement of Drugs/ Supplies (category-III-VIII) for the year 2025-26

Essential Drugs Division

"KMSCL- Re-tender for the Procurement of Bleaching Power for the year 2025-26".

Essential Drugs Division

KMSCL: Re-Tender for the procurement & supply of Drugs for Thalassemia for the year 2024-25 vide re-tender No-KMSCL/ED/THALASSEMIA DRUGS/RT/2025/013 dtd 28-06-2025.

Essential Drugs Division

KMSCL- Re- tender for the Procurement of Drugs for the year 2025-26- Technical Bid Evaluation- Defects noticed/ status- Published- reg

Essential Drugs Division

KMSCL- Re- tender for the Procurement of Specialty Drugs for the year 2025-26- Technical Bid Evaluation- Defects noticed and status- Published

Essential Drugs Division

Notice for rejection/acceptance of item/bidder for price bid evaluation of e-tender for the procurement & supply of Salt Testing kit for NIDDCP for the year 2024-25

Essential Drugs Division

KMSCL Pre- tender zoom meeting vide e-tender for the procurement of Bleaching Powder 2025-26

Essential Drugs Division

E-tender for the Procurement of Drugs/ Supplies for the year 2025-26 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published

Essential Drugs Division

E-tender for the Procurement of Drugs for the year 2025-26 -Price Bid Evaluation - Final Bid Status - Published

Essential Drugs Division

E-tender for the Procurement of Specialty Drugs for the year 2025-26 -Price Bid Evaluation -Final Bid Status - Published

Essential Drugs Division

KMSCL e- tender for the procurement of Bleaching Powder for the year 2025-26

Essential Drugs Division

Re-TENDER DOCUMENT FOR THE PROCUREMENT OF SPECIALTY DRUGS

Essential Drugs Division

Re-tender for the procurement of drugs for the year 2025-26

Essential Drugs Division

Procurement & Supply of Drugs for Ankylosing Spondylitis for KSSM for the year 2025-26

Essential Drugs Division

e-tender for the Procurement of drugs/supplies for the year 2025-26 - Technical Bid Evaluation - List of selected/Rejected/bidders/products for price bid evaluation published

Essential Drugs Division

Technical Bid Evaluation/Sample Evaluation of Tender for the procurement& supply of Salt testing Kit for NIDDCP for 2024-25

Essential Drugs Division

e-tender for the procurement of Drug for Palliative care for the year 2025-26

Essential Drugs Division

Re-tender for the Procurement and supply of drugs for Multiple Scieosis for KSSM for the year 2025-26

Essential Drugs Division

Procurement of Anti-Cancer Drugs for the year 2025-26 – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

KMSCL – E-tender for the Procurement of Anti Cancer Drugs for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published

Essential Drugs Division

Re-tender for the Procurement & Supply of Insecticides for NVBDCP & Plan Scheme for the year 2023-24 & 2024-25

Essential Drugs Division

Re-Tender for the Procurement of Test kits for NVBDCP AND PLAN FUND for the year 2023-24 AND 2024-25

Essential Drugs Division

E-tender for the Procurement of Specialty Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier-wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

e-tender for the procurement of drugs for the year 2025-26 - Price Bid Evaluation – Notice on Supplier-wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

KMSCL – E-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg

Essential Drugs Division

KMSCL- E-tender for the Procurement of Drugs for the year 2025-26 ( category I&II) - Technical Bid Evaluation - List of selected/rejected bidders/products for Price Bid Evaluation- Published- reg

Essential Drugs Division

KMSCL-e- Tender for the procurement of Drugs for MULTIPLE SCLEROSIS FOR KSSM fro the year 2025-26

Essential Drugs Division

KMSCL- E- tender for the Procurement of Drugs/ Supplies for the year 2025-26- Technical Bid Evalution- Defects Noticed/ Status - Published- reg(Category III-VIII)

Essential Drugs Division

Procurement of Insecticides for NVBDCP & Plan fund for the year 2023-24 & 2024-25– Price Bid Evaluation – FINAL Bid Status–published

Essential Drugs Division

E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25 –Price Bid Evaluation– Final Bid Status- Published

Essential Drugs Division

E-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed and status– Published

Essential Drugs Division

E-tender for the Procurement of Anti Cancer Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed and status– Published

Essential Drugs Division

e-tender for the procurement of drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed/status – Published – reg"

Essential Drugs Division

Provisional Bid Status of E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25

Essential Drugs Division

E-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2023-24 & 2024-25 vide etender No- KMSCL/ED/INS-NVBDCP&Plan/RC/2024/017

Essential Drugs Division

KMSCL – Re-Tender for the supply of Insulin Cartridge and Pen for Mittayi Project for 2024-25– Price bid evaluation-Final Bid ranking status-–Published

Essential Drugs Division

KMSCL –E-Tender for Procurement & Supply of Drugs for Thalassemia Management for 2024-25 – Price bid evaluation-Final Bid ranking status – Published

Essential Drugs Division

KMSCL-E-tender for the Procurement of Deworming Medicines for the year 2024-25-Price Bid Evaluation- Final Bid status -Published

Essential Drugs Division

KMSCL-E-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2023-24 & 2024-25- List of selected/Rejected Bidders/ products for Price Bid Evaluation- published- reg

Essential Drugs Division

List of Selected/Rejected Bidders/ Products for Price Bid Evaluation-for– E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25 vide tender No- KMSCL/ED/NVBDCP &Plan Test Kits/RC/2024/022

Essential Drugs Division

KMSCL-E-Tender for the procurement & supply of Drugs for Thalassemia Management for 2024-25- Price bid evaluation- Provisional Bid ranking status- Published - reg

Essential Drugs Division

KMSCL-Re-Tender for the supply of Insulin Cartridge and pen for Mittayi Project for 2024-25- Price bid evaluation- Provisional Bid ranking status- Published - reg

Essential Drugs Division

KMSCL- E-tender for the Procurement of Deworming Medicines for the year 2024-25- Price Bid Evaluation- Notice on Supplier wise rate quoted and Provisional Bid Ranking Status- Published- reg

Essential Drugs Division

Re-Tender for the supply of Insulin Cartridge and Pen for Mittayi Project for 2024-25– List of selected/ rejected bidders/products for price bid evaluation-–Published–reg

Essential Drugs Division

E-Tender for Procurement & Supply of Drugs for Thalassemia Management for 2024-25 – List of Selected/Rejected Bidders/ Products for Price Bid Evaluation– Published – reg

Essential Drugs Division

KMSCL – E-tender for the Procurement of Deworming Medicines for the year 2024-25 – Technical Bid Evaluation –List of selected /rejected bidders/products for price bid evaluation– Published – reg

Essential Drugs Division

KMSCL- E- tender for the Procurement of Drug for Rare Disease for SATH under NPRD for the year 2024-25 - Bidder eligible for the Price Bid Evalution- Published- reg

Essential Drugs Division

E-tender for the Procurement of Veterinary Medicines for the year 2024-25 – Technical Bid Evaluation – Defects noticed/status– Published

Essential Drugs Division

E-tender for the Procurement of IMIGLUCERASE for Injection 400 units for SATH under NPRD for the year 2024-25 – Technical Bid Evaluation – Defects noticed/status– Published

Essential Drugs Division

KMSCL-E-tender for the Procurement of Deworming Medicines to the Animal Husbandry Department for the year 2024-25

Essential Drugs Division

KMSCL- E-tender for the Procurement of Veterinary Medicines for the year 2024-25- Technical Bid Evaluation - Defects noticed/status- Published- reg

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Drugs/Supplies (Category III-VIII) for the year 2024-25- Final Bid Status- Corrigendum- Published-reg.

Essential Drugs Division

KMSCL – E-tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Price Bid Evaluation – Final Bid status -Published – reg

Essential Drugs Division

KMSCL-E- tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25- Price Bid Evaluation- Final Bid status- Published- reg. Vide e-tender No- KMSCL/ED/RD-SAT/RC/2024/019 dated. 27.09.2024

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Anti- cancer Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg

Essential Drugs Division

Re-tender for the Procurement of Drugs for the year 2024-25– Price Bid Evaluation – Final Bid Status– Published

Essential Drugs Division

FOR THE PROCUREMENT OF TEST KITS FOR NVBDCP and PLAN FUND

Essential Drugs Division

FOR THE PROCUREMENT OF TEST KITS FOR NVBDCP and PLAN FUND

Essential Drugs Division

Re-tender for the supply of Insulin Cartridge and Pen for the year 2024-25

Essential Drugs Division

Provisional Bid ranking status of Price bid evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24